首页> 外文期刊>Seminars in cancer biology >H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells.
【24h】

H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells.

机译:H1组胺受体拮抗剂抑制Jurkat T细胞的组成性生长和卵清蛋白特异性鼠T细胞的抗原特异性增殖。

获取原文
获取原文并翻译 | 示例
           

摘要

Histamine is produced from histidine by histidine decarboxylase (HDC) in many cells including normal and malignant lymphocytes. We examined the expression of HDC and the effect of histamine receptor antagonists on the proliferation of a human T cell line, Jurkat and on antigen-driven proliferation of lymphocytes from ovalbumin-immunized mice. Our results demonstrate that HDC is inducible in Jurkat cells by anti-CD3. The H1 receptor antagonist triprolidine dose dependently inhibits proliferation of both Jurkat cells and ovalbumin-stimulated murine lymphocytes, while the H2 antagonist ranitidine was ineffective. Alpha-fluoro-methyl-histidine blocking HDC activity did not inhibit the T cell proliferation, suggesting an existing pool of histamine in T cells.
机译:组胺是通过组氨酸脱羧酶(HDC)由组氨酸在许多细胞中产生的,包括正常和恶性淋巴细胞。我们检查了HDC的表达以及组胺受体拮抗剂对人T细胞系Jurkat的增殖以及卵清蛋白免疫小鼠淋巴细胞的抗原驱动的增殖的影响。我们的结果表明,抗CD3可在Jurkat细胞中诱导HDC。 H1受体拮抗剂雷帕替丁剂量依赖性地抑制Jurkat细胞和卵清蛋白刺激的鼠淋巴细胞的增殖,而H2拮抗剂雷尼替丁无效。阻止HDC活性的α-氟甲基甲基组氨酸不能抑制T细胞增殖,提示T细胞中存在组胺。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号